Skip to main content
Fig. 2 | Skeletal Muscle

Fig. 2

From: A novel chemical-combination screen in zebrafish identifies epigenetic small molecule candidates for the treatment of Duchenne muscular dystrophy

Fig. 2

Timeline of dmd mutant zebrafish small molecule treatments. Eggs are collected from crosses of dmd+/− fish. dmd is autosomal recessive in zebrafish, so about 25% of embryos will be dmd−/−. At 1 dpf (days post-fertilization), embryos are sorted into dishes for treatments, and DMSO or small molecule compounds are added to the embryo bath (as in [27]). Treatment media are replaced daily. At 4 dpf, animals are fixed and muscle birefringence is scored. dmd−/− animals exhibit dark lesions in the larval trunk muscle (arrow in image), as visualized using polarized light birefringence

Back to article page